ZA991315B - Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. - Google Patents
Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.Info
- Publication number
- ZA991315B ZA991315B ZA9901315A ZA991315A ZA991315B ZA 991315 B ZA991315 B ZA 991315B ZA 9901315 A ZA9901315 A ZA 9901315A ZA 991315 A ZA991315 A ZA 991315A ZA 991315 B ZA991315 B ZA 991315B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- benign prostatic
- prostatic hyperplasia
- novel substituted
- substituted pyridino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7532198P | 1998-02-20 | 1998-02-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA991315B true ZA991315B (en) | 2000-11-20 |
Family
ID=22124955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9901315A ZA991315B (en) | 1998-02-20 | 1999-02-18 | Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6218396B1 (de) |
| EP (1) | EP1054868B1 (de) |
| JP (1) | JP2002503724A (de) |
| KR (1) | KR100591028B1 (de) |
| CN (1) | CN1121390C (de) |
| AR (1) | AR014626A1 (de) |
| AT (1) | ATE250580T1 (de) |
| AU (1) | AU766398B2 (de) |
| BR (1) | BR9909647A (de) |
| CZ (1) | CZ294136B6 (de) |
| DE (1) | DE69911582T2 (de) |
| DK (1) | DK1054868T3 (de) |
| ES (1) | ES2209468T3 (de) |
| HK (1) | HK1030776A1 (de) |
| HU (1) | HUP0100781A3 (de) |
| IL (2) | IL137954A0 (de) |
| NO (1) | NO317103B1 (de) |
| NZ (1) | NZ506462A (de) |
| PL (1) | PL342339A1 (de) |
| PT (1) | PT1054868E (de) |
| TR (1) | TR200003220T2 (de) |
| TW (1) | TW565555B (de) |
| WO (1) | WO1999042448A1 (de) |
| ZA (1) | ZA991315B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0100048A3 (en) * | 1997-05-12 | 2002-12-28 | Ortho Mcneil Pharm Inc | Arylsubstituted piperazine-derivatives, useful in the treatement of benign prostatic hyperlasia use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them |
| AU2001281121B2 (en) | 2000-08-08 | 2007-08-23 | Ortho-Mcneil Pharmaceutical, Inc. | Non-imidazole aryloxypiperidines as H3 receptor ligands |
| BR0215389A (pt) * | 2001-12-28 | 2004-10-26 | Takeda Chemical Industries Ltd | Agente preventivo ou terapêutico para distúrbio urinário, método para prevenir ou tratar distúrbio urinário, uso de um composto, composto, pró-droga, processo para preparar o composto, medicamento, e, método para triar um composto |
| EP2077262A4 (de) * | 2006-10-23 | 2011-12-28 | Takeda Pharmaceutical | Iminopyridinderivate und deren verwendung |
| US20110039892A1 (en) * | 2008-04-23 | 2011-02-17 | Takeda Pharmaceutical Company Limited | Iminopyridine derivative and use thereof |
| US8481569B2 (en) | 2008-04-23 | 2013-07-09 | Takeda Pharmaceutical Company Limited | Iminopyridine derivatives and use thereof |
| ES2478823T3 (es) * | 2008-04-23 | 2014-07-23 | Takeda Pharmaceutical Company Limited | Derivados de iminopiridina y uso de los mismos |
| CN103980195A (zh) * | 2014-04-28 | 2014-08-13 | 广州医科大学 | 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用 |
| CN108530391B (zh) * | 2018-05-17 | 2022-05-17 | 袁牧 | 一种酰胺类芳基哌嗪衍生物及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2027898A6 (es) * | 1991-01-24 | 1992-06-16 | Espanola Prod Quimicos | Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina. |
| US5403847A (en) | 1992-11-13 | 1995-04-04 | Synaptic Pharmaceutical Corporation | Use of α1C specific compounds to treat benign prostatic hyperlasia |
| IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
| DE4425146A1 (de) * | 1994-07-15 | 1996-01-18 | Basf Ag | Verwendung heterocyclischer Verbindungen |
| US5688795A (en) * | 1994-11-08 | 1997-11-18 | Syntex (U.S.A.) Inc. | 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists |
| WO1999003833A1 (en) * | 1997-07-15 | 1999-01-28 | Sankyo Company, Limited | Piperazine derivatives |
-
1999
- 1999-02-18 US US09/252,313 patent/US6218396B1/en not_active Expired - Lifetime
- 1999-02-18 ZA ZA9901315A patent/ZA991315B/xx unknown
- 1999-02-19 DK DK99934281T patent/DK1054868T3/da active
- 1999-02-19 ES ES99934281T patent/ES2209468T3/es not_active Expired - Lifetime
- 1999-02-19 PL PL99342339A patent/PL342339A1/xx unknown
- 1999-02-19 DE DE69911582T patent/DE69911582T2/de not_active Expired - Fee Related
- 1999-02-19 JP JP2000532400A patent/JP2002503724A/ja active Pending
- 1999-02-19 IL IL13795499A patent/IL137954A0/xx active IP Right Grant
- 1999-02-19 CN CN99803027A patent/CN1121390C/zh not_active Expired - Fee Related
- 1999-02-19 AU AU33025/99A patent/AU766398B2/en not_active Ceased
- 1999-02-19 CZ CZ20003044A patent/CZ294136B6/cs not_active IP Right Cessation
- 1999-02-19 WO PCT/US1999/003608 patent/WO1999042448A1/en active IP Right Grant
- 1999-02-19 KR KR1020007009156A patent/KR100591028B1/ko not_active IP Right Cessation
- 1999-02-19 EP EP99934281A patent/EP1054868B1/de not_active Expired - Lifetime
- 1999-02-19 BR BR9909647-1A patent/BR9909647A/pt not_active Application Discontinuation
- 1999-02-19 PT PT99934281T patent/PT1054868E/pt unknown
- 1999-02-19 AT AT99934281T patent/ATE250580T1/de not_active IP Right Cessation
- 1999-02-19 NZ NZ506462A patent/NZ506462A/en unknown
- 1999-02-19 HU HU0100781A patent/HUP0100781A3/hu unknown
- 1999-02-19 TR TR2000/03220T patent/TR200003220T2/xx unknown
- 1999-02-23 AR ARP990100675A patent/AR014626A1/es active IP Right Grant
- 1999-04-02 TW TW088102511A patent/TW565555B/zh not_active IP Right Cessation
-
2000
- 2000-08-18 NO NO20004141A patent/NO317103B1/no not_active IP Right Cessation
- 2000-08-18 IL IL137954A patent/IL137954A/en not_active IP Right Cessation
-
2001
- 2001-03-08 HK HK01101679A patent/HK1030776A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9909647A (pt) | 2000-11-21 |
| IL137954A (en) | 2007-06-03 |
| ATE250580T1 (de) | 2003-10-15 |
| AR014626A1 (es) | 2001-03-28 |
| CZ294136B6 (cs) | 2004-10-13 |
| TR200003220T2 (tr) | 2001-04-20 |
| HK1030776A1 (en) | 2001-05-18 |
| DK1054868T3 (da) | 2003-12-22 |
| HUP0100781A3 (en) | 2002-12-28 |
| TW565555B (en) | 2003-12-11 |
| EP1054868B1 (de) | 2003-09-24 |
| NO317103B1 (no) | 2004-08-09 |
| CN1291188A (zh) | 2001-04-11 |
| WO1999042448A1 (en) | 1999-08-26 |
| CN1121390C (zh) | 2003-09-17 |
| NO20004141L (no) | 2000-10-19 |
| JP2002503724A (ja) | 2002-02-05 |
| EP1054868A1 (de) | 2000-11-29 |
| NZ506462A (en) | 2003-07-25 |
| AU766398B2 (en) | 2003-10-16 |
| CZ20003044A3 (cs) | 2001-04-11 |
| HUP0100781A2 (hu) | 2001-08-28 |
| IL137954A0 (en) | 2001-10-31 |
| AU3302599A (en) | 1999-09-06 |
| PT1054868E (pt) | 2004-01-30 |
| KR100591028B1 (ko) | 2006-06-22 |
| PL342339A1 (en) | 2001-06-04 |
| DE69911582D1 (de) | 2003-10-30 |
| ES2209468T3 (es) | 2004-06-16 |
| US6218396B1 (en) | 2001-04-17 |
| DE69911582T2 (de) | 2005-09-15 |
| NO20004141D0 (no) | 2000-08-18 |
| KR20010041115A (ko) | 2001-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993396L (no) | Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi | |
| AU1316000A (en) | Compositions and methods for treating benign prostatic hyperplasia using tocotrienols | |
| AU3011299A (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
| IL141235A0 (en) | Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi | |
| AU1657097A (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
| EP0855910A4 (de) | Verwendbare konjugate zur behandlung der gutartigen prostatehyperplasie | |
| ZA991315B (en) | Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. | |
| ZA983968B (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia. | |
| HK1048318A1 (en) | Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors. | |
| ZA982819B (en) | Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators. | |
| AU3896899A (en) | Compositions for the treatment of tumors, and uses thereof | |
| ZA991319B (en) | Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia. | |
| BG104914A (en) | Paroxetine maleate | |
| EP0633781A4 (de) | Zusammensetzungen und verfahren zur behandlung der benignen prostatahypertropie. | |
| HK1049485A1 (en) | DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses. | |
| EP1140906A4 (de) | Imidazolone und ihre anwendung bei der behandlung von benigner prostatahyperplasie und anderen störungen | |
| AU2002232403A1 (en) | Del-1 and benign prostatic hyperplasia | |
| GB9602903D0 (en) | Conjugates useful in the treatment of benign prostatic hyperplasia | |
| HK1045506A1 (en) | Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods | |
| GB9810895D0 (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
| AU2002300904A1 (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia | |
| ZA988293B (en) | Compositions and methods for the treatment of tumor. | |
| ZA200202930B (en) | Methods and compositions utilizing quinazolinones. | |
| AU2003204320A1 (en) | Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof | |
| AU2002239466A1 (en) | Gene associated with benign prostatic hyperplasia in humans |